Protein Foundry

Executive Summary

Protein Foundry is a specialized biotechnology company that supplies high-quality recombinant chemokines to the biomedical research community. Based in Madison, Wisconsin, and founded in 2015, the company offers a comprehensive catalog covering nearly all human and mouse chemokines, available with various labels and tags. It also provides custom production and stable isotope labeling services, with a strong focus on preserving native protein structures—particularly the N-terminal sequence—to ensure full biological activity. By addressing the critical need for structurally intact chemokines in research, Protein Foundry supports studies in immunology, inflammation, and drug development. As a private company with no disclosed funding or revenue details, its market position is niche but potentially growing due to the rising demand for high-quality recombinant proteins in the expanding proteomics and synthetic biology fields. The company's emphasis on quality and native conformation positions it as a key supplier for academic and pharmaceutical research labs.

Upcoming Catalysts (preview)

• Q4 2026Expansion of Chemokine Catalog or New Labeling Options70% success
• Q1 2027Strategic Partnership or Distribution Agreement with Major Research Reagent Distributor40% success
• Q2 2027Announcement of First Institutional or Commercial Research Collaboration30% success